News and Press Releases
About the CF Foundation | Public Policy | Research NIH Director Francis Collins and CF Foundation to Brief U.S. Senate on Advancing Disease Research

Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies

| 3 min read
Research FDA Approves Third Pancreatic Enzyme Product: Pancreaze Delayed-Release Capsules

The U.S. Food and Drug Administration (FDA) has approved PancreazeTM delayed-release capsules, a pancreatic enzyme replacement therapy. This is the third such product to receive approval. Pancreaze is manufactured by Johnson & Johnson.

| 1 min read
Research CF Foundation Plays Important Role in Bringing New Inhaled Antibiotic Cayston to Patients

The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis (CF). 

| 3 min read